Massive Bio, Inc.
Massive Bio is an AI-powered platform that transforms cancer treatment access by connecting patients to clinical trials worldwide. They focus on removing barriers like geography and financial constraints, aiming to provide equitable access to innovative therapies for cancer patients.
Massive Bio is a healthcare technology company that uses AI-driven cancer analysis and clinical trial matching to connect oncology patients with appropriate investigational therapies. Their platform integrates clinical and genomic data to identify and prioritize trial matches, streamline referrals, and simplify enrollment workflows for hospitals, cancer centers, and life‑science sponsors. The company also offers patient navigation, molecular tumor board support, and site activation services to improve the patient experience and boost trial accrual. Massive Bio works with health systems, biopharma, and CRO partners to accelerate precision oncology research and broaden access to clinical trials.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Massive Bio, Inc..
Massive Bio, Inc. didn’t post a salary, so this is our estimate from similar listings.
Patient Navigator, (South Korea or Australia)
myTomorrows
Cancer Screening Patient Navigator/Hybrid
BMC Company
Patient Navigator - Research Focus
Dana-Farber Cancer Institute
Patient Care Navigator - Breast Surgery
Summit Health
Physician - Medical Breast Oncology
Ochsner Health
Patient Navigator (Cancer Treatment)
Tidelands Health